United States: FDA Issues Guidance On Registration, Fees And Reporting Requirements For Drug Compounding Outsourcing Facilities

On November 21, 2014, the U.S. Food and Drug Administration (FDA) announced the release of three new guidance documents related to drug compounding outsourcing facilities.[1] These documents include:

  • Final Guidance on registration of human drug compounding outsourcing facilities
  • Final Guidance on registration fees for such outsourcing facilities
  • Revised Draft Guidance on electronic drug product reporting requirements for compounding outsourcing facilities

As detailed in an earlier Duane Morris Alert, the 2013 Drug Quality and Securities Act (DQSA) added Section 503B to the Food, Drug, and Cosmetic Act (FDCA), which established federal oversight for human drug compounding outsourcing pharmacies (outsourcing facilities). Compounds for human use prepared in outsourcing facilities compliant with Section 503B are exempt from FDCA new drug approval and the adequate directions for use labeling requirements; outsourcing facilities, however, are still subject to certain current Good Manufacturing Practices (cGMPs).[2] The newly issued guidance documents provide further insight into FDA's current position on certain requirements for outsourcing facilities.

Final Guidance on Registration of Outsourcing Facilities

The Final Guidance on registration sets out the procedure by which a compounder must register with FDA. For its initial registration or annual renewal, an outsourcing facility must submit general information, including whether the facility will compound drugs on FDA's drug shortage list, and whether the facility will compound from bulk drug substances. Registration generally should be completed electronically, although a waiver is available if a facility cannot register electronically. Registration is not complete until FDA assesses the registration fee and that fee is paid.

Final Guidance on Registration Fees

The Final Guidance on registration fees finalizes the draft guidance discussed in an earlier Duane Morris Alert. Beginning with fiscal year (FY) 2015, outsourcing facilities must pay an annual establishment fee during the October 1 to December 31 registration period.[3] A facility is not considered to be registered for the following year until it has submitted registration information and paid the annual establishment fee, both of which must be completed by December 31. Drugs compounded when an outsourcing facility is not registered do not qualify for the Section 503B exemptions to new drug approval and the adequate labeling requirements.

Annual Establishment Fee and Adjustment Factors

The annual establishment fee, discussed in greater detail in the earlier Duane Morris Alert, is equal to $15,000 multiplied by the inflation adjustment factor plus a small business adjustment factor. The inflation adjustment factor, determined by a formula described in the Final Guidance, compounds each year such that it is calculated using the prior year's inflation-adjusted establishment fee. The small business adjustment factor, added to the establishment fees assessed for all facilities not qualifying as small businesses, is equal to the total fees "lost" from facilities qualifying as small businesses, divided by the number of non-qualifying facilities.

Every outsourcing facility must pay the full establishment fee, regardless of when during the calendar year it registers as an outsourcing facility.

Small Business Fee Reduction Eligibility

An outsourcing facility may submit a written request for a small business fee reduction. If deemed to be a small business, the facility will pay an establishment fee of only $5,000 multiplied by the inflation adjustment factor. In order for a facility to be eligible for the reduction, its worldwide gross annual sales must be $1,000,000 or less (in U.S. dollars) during the 12 months ending on April 1 of the fiscal year preceding that in which the fee is assessed. Such gross annual sales include all sales from affiliates, regardless of whether those sales relate to compounding products or other drugs.

Payment of Fees

After an outsourcing facility has submitted its annual registration information, FDA will email the facility an invoice specifying the establishment fee the facility is required to pay. Unlike in the earlier draft guidance, the Final Guidance makes no statements as to how long FDA anticipates the invoicing process to take. Once an invoice is issued, a facility must pay the fee within 15 calendar days or FDA will consider the facility's registration information to have been withdrawn.[4] In order to ensure sufficient time for this process, FDA recommends that outsourcing facilities submit their registration information by December 10 of each year.

Reinspection Fees

If FDA reinspects an outsourcing facility, the facility is required to pay a reinspection fee for each such reinspection. Reinspection fees will be equal to $15,000 multiplied by the inflation adjustment factor. Small business reductions are not available for reinspection fees. Once a reinspection is complete, FDA will email the invoice for the reinspection fee within 14 calendar days. If the facility does not pay the fee within 30 calendar days of the invoice date, the fee will be subject to interest and fees until paid in full.

Dispute Resolution

An outsourcing facility that wishes to dispute an assessed fee or the denial of small business status may request reconsideration of FDA's original decision. The outsourcing facility may submit a further appeal of a denial of reconsideration to the Director of the Division of User Fee Management and Budget Formulation.

Revised Draft Guidance on Drug Product Reporting Requirements

This revised Draft Guidance provides FDA's current approach on drug product reporting required under Section 503B. Unlike most FDA guidance documents, which are simply advisory, as prescribed by Section 503B, the final version of this guidance will have the force and effect of law—i.e., it will be binding.

Pursuant to section 503B of the FDCA, facilities must file drug product reports upon initial registration and thereafter on a twice-yearly basis. According to the Guidance, these reports must be submitted electronically (unless the facility obtains a waiver), between June 1 and June 30, covering the period between December 1 and May 31; and between December 1 and December 31, covering the period between June 1 and November 30.

Drug product reports have to list all drugs that the facility has compounded in the six-month reporting period. For each of these drugs, the facility is required to provide information about:

  • Active ingredient and strength of that ingredient per dose
  • Source of active ingredient—i.e., whether it is a bulk or finished drug
  • National Drug Code (NDC) number for source drug or bulk active ingredient, if available
  • Dosage form and route of administration
  • Package description, including type and volume of smallest saleable package
  • Number of individual units in smallest saleable package
  • NDC number of final product, if assigned.

FDA will be accepting comments on the Draft Guidance through January 23, 2015, both electronically, at http://www.regulations.gov, and in writing, to the Division of Dockets Management. Further details on the procedure for submitting comments to the Draft Guidance are available on FDA's notice in the Federal Register.


As outsourcing facilities are still a relatively new category of registrant under the FDCA, FDA is continuing to issue guidance documents as to its current thinking on Section 503B's requirements.

For Further Information

If you have any questions about this Alert or would like more information, please contact Rachael G. Pontikes, Alison T. Rosenblum, any of the attorneys in our Pharmaceutical, Medical Device, Pharmacy and Food industry group or the attorney in the firm with whom you are regularly in contact.


  1. Official notices for each of the guidance documents were published in the Federal Register on November 24, 2014.
  2. Regulations have not been promulgated regarding the cGMP requirements with which outsourcing facilities must comply. FDA issued interim guidance as to its cGMP expectations for outsourcing facilities on July 2, 2014. For further discussion of these requirements, please see our related Duane Morris Alert.
  3. Outsourcing facilities that registered prior to October 1, 2014, need not pay an establishment fee for FY 2014. Fees for FY 2015 were announced in the Federal Register on August 1, 2014.
  4. Once an outsourcing facility pays the establishment fee, refunds are not available, even if the facility subsequently withdraws its registration.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions